Mark Peter Brennan Purchases 25,000 Shares of Ascendant Resources Inc (ASND) Stock

Ascendant Resources Inc (TSE:ASND) Director Mark Peter Brennan acquired 25,000 shares of Ascendant Resources stock in a transaction on Tuesday, May 16th. The shares were bought at an average price of C$0.75 per share, for a total transaction of C$18,750.00.

Mark Peter Brennan also recently made the following trade(s):

  • On Wednesday, May 10th, Mark Peter Brennan acquired 22,500 shares of Ascendant Resources stock. The shares were bought at an average price of C$0.73 per share, for a total transaction of C$16,425.00.
  • On Monday, May 1st, Mark Peter Brennan acquired 6,500 shares of Ascendant Resources stock. The shares were bought at an average price of C$0.67 per share, for a total transaction of C$4,355.00.
  • On Tuesday, May 2nd, Mark Peter Brennan acquired 4,000 shares of Ascendant Resources stock. The shares were bought at an average price of C$0.67 per share, for a total transaction of C$2,680.00.
  • On Thursday, April 27th, Mark Peter Brennan acquired 50,000 shares of Ascendant Resources stock. The shares were bought at an average price of C$0.70 per share, for a total transaction of C$35,000.00.
  • On Wednesday, April 26th, Mark Peter Brennan acquired 38,000 shares of Ascendant Resources stock. The shares were bought at an average price of C$0.65 per share, for a total transaction of C$24,700.00.
  • On Tuesday, April 25th, Mark Peter Brennan acquired 200,000 shares of Ascendant Resources stock. The shares were bought at an average price of C$0.60 per share, for a total transaction of C$120,000.00.
  • On Wednesday, April 19th, Mark Peter Brennan acquired 287,000 shares of Ascendant Resources stock. The shares were bought at an average price of C$0.63 per share, for a total transaction of C$180,810.00.

Insider Buying and Selling by Quarter for Ascendant Resources (TSE:ASND)

ILLEGAL ACTIVITY NOTICE: “Mark Peter Brennan Purchases 25,000 Shares of Ascendant Resources Inc (ASND) Stock” was first published by Mideast Time and is owned by of Mideast Time. If you are reading this piece on another site, it was stolen and reposted in violation of international copyright legislation. The legal version of this piece can be viewed at https://www.mideasttime.com/mark-peter-brennan-purchases-25000-shares-of-ascendant-resources-inc-asnd-stock/1708497.html.

Ascendant Resources Company Profile

Ascendis Pharma A/S is a clinical-stage biopharmaceutical company. The Company is engaged in applying its TransCon technology to develop sustained release prodrug therapies with several product candidates in clinical and preclinical development. The Company is developing its product candidate, TransCon human growth hormone (TransCon hGH) for once-weekly administration to treat growth hormone deficiency (GHD) and other indications.

Receive News & Ratings for Ascendant Resources Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascendant Resources Inc and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.